Guidelines: Safe-by-design for medicinal polymeric nanocarriers

novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The  Swiss partners in the consortium were funded by Innosuisse.

Related articles

Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Developing trends in nano... Waste containing nanomaterials — or nanowaste — is an emerging safety concern worldwide, warranting specific environmentally sound waste management and regulation. Authors: Arturo A. Keller, Alex Ehrens, Yuanfang Zheng & Bernd
Swiss NanoConvention Dr. Peter Wick represented contactpointnano and Empa at the Swiss NanoConvention in Neuchâtel (June 15-16, 2023). This year, the topics included nanoimaging, advanced manufacturing at nanoscale, smart
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of talks to Empa Quarterly about recent antibody studies, which are